Publication: Learning from the Republic of Korea: Building Health System Resilience
Loading...
Date
2023-08-15
ISSN
Published
2023-08-15
Author(s)
Editor(s)
Abstract
The response of the government of the Republic of Korea to COVID-19 has been heralded as among the most successful. In the first two years of the pandemic, the government was able to keep the size of the outbreak relatively small and the death toll relatively low. Although the number of COVID-19 cases jumped significantly subsequently in 2022 and 2023 due to the spread of the more transmissible Omicron variant and a revamped testing regime that cast a broader net to detect infections, Korea had a much lower rate of total confirmed COVID-19 deaths per million population than other high income countries (676 in Korea, as compared to 3,379 in the United Kingdom, 3,331 in the United States, and 2,599 in France). The government achieved this relatively positive result without resorting to the highly restrictive measures that were adopted by most high-income countries, such as strictly controlling borders, shuttering businesses, or issuing severe lockdown or stay-at-home orders. Indeed, since the start of the outbreak in January 2020, the distinguishing features of the response in Korea include the government’s ability to mobilize swiftly, even in the early stages of the pandemic, to flatten the epidemic curve. This report dissects the COVID-19 countermeasures successfully adopted in Korea. The analysis draws out insights and lessons that may be relevant to other countries as they mount responses to ongoing crises and prepare for future public health emergencies.
Link to Data Set
Citation
“Wang, Huihui; Hwang, Inuk; Marquez, Patricio V.. 2023. Learning from the Republic of Korea: Building Health System Resilience. Pharmacovigilance and Essential Public Health Services Series. © World Bank. http://hdl.handle.net/10986/40203 License: CC BY-NC 3.0 IGO.”
Associated URLs
Associated content
Other publications in this report series
Journal
Journal Volume
Journal Issue
Collections
Related items
Showing items related by metadata.
Publication The Value of Pharmacovigilance in Building Resilient Health Systems Post-COVID(World Bank, Washington, DC, 2023-08-15)Although indispensable for improving health outcomes, medicines and vaccines or their administration and use can produce adverse effects, requiring continuous vigilance to ensure that the benefits outweigh the risks. Monitoring the safety of the use of marketed medicines and vaccines, also known as pharmacovigilance, should therefore become much more explicit in efforts to strengthen health systems and prepare for public health crises and normal times because the world is determined to build back better after the COVID-19 pandemic. The objective of this report is to examine the importance of pharmacovigilance in a health system both during a health crisis and in normal times, describe the function, structure, and processes of a functional pharmacovigilance system, and explain the value of drug safety monitoring in building resilience in health systems post-COVID-19 pandemic.Publication Starting and Strengthening a National Pharmacovigilance System(World Bank, Washington, DC, 2023-08-15)The Spanish System of Pharmacovigilance (SSPV) started its activities almost 40 years ago, in 1985. Of particular interest to others considering various options for developing pharmacovigilance systems is the fact that this case study highlights an example that built from the ground up and actually started in academia: the SSPV began as a research project in a university institution in Catalonia that was later adopted by the Ministry of Health. From these origins, a regulatory framework gradually allowed this initiative to expand to the whole country. In 1990, after technical training for the professional staff involved, responsibility for coordinating the system was transferred to a specially created coordinating center for the SSPV located in the Spanish Medicines Agency. This report reviews the origins of the system and its key features, followed by two examples of the system in action and closing comments on aspects and lessons that may be of particular value to others developing pharmacovigilance systems elsewhere.Publication Overview of the Republic of Korea Pharmacovigilance System(World Bank, Washington, DC, 2023-08-15)Building capacity in countries to conduct thorough surveillance of the use of all newly authorized drugs and vaccines, both brand name and generic, is a critical “public good” investment to ensure that drugs work correctly and that their health benefits outweigh their known risks. Korea’s pharmacovigilance system (PVS) is an international best practice. It is the result of a continuous and sustained government effort over the past three decades—from small pilot projects to a nationwide monitoring network—and offers valuable lessons to other countries on the vital role that such a system can play in ensuring the safety of drugs post-marketing. This report provides an overview of the Korean pharmacovigilance system, describing its main structural and operational elements, to monitor the safety and effectiveness of medicines. It draws from a review of available literature in journal articles, as well as from the websites and reports of Korean institutions.Publication Why is the Safety of Medicines Important for Resilient Health Systems? A Synthesis Report(Washington, DC: World Bank, 2023-08-22)This report discusses the importance of pharmacovigilance (PV) in contributing to building up resilient health systems. It is based on and summarizes the findings of a review of available literature on the topic and relevant case studies focusing on a set of country and regional experiences. Although indispensable in improving health outcomes, the administration and use of medicines may produce adverse reactions, requiring continuous monitoring to ensure that the benefits outweigh the risks. PV, which involves the systematic detection, reporting, assessment, understanding, and prevention of adverse drug reactions (ADRs), is an essential public health function, but it is often overlooked. The review suggests that successful PV programs are built on three essential pillars: statutory provisions that establish standards for PV centers and programs, well-trained health professionals and associated stakeholders, and engaged PV reporters using effective reporting systems. These pillars allow PV programs to be effective in three core activities: reporting adverse drug events (ADEs) and identifying signals, determining threats through a benefit-risk balance analysis, and taking appropriate actions. This is in addition to supporting various functions of a health system, such as national drug policy and regulation, the delivery of medical care, specific disease control programs, increasing the trust of the general public in the system, and promoting eco-PV. Aided by emerging opportunities for development through automation and machine learning, PV programs show immense potential to enhance the monitoring of patient safety and improve the use of medicines. The report offers policy considerations for countries and international partners in building PV capacity as an essential public function of a health system.Publication Pharmacovigilance in Brazil(World Bank, Washington, DC, 2023-08-15)The ability to oversee and monitor the use of all newly authorized drugs and vaccines, both brand name and generic, is critical to ensure that they work correctly and that their health benefits outweigh their known risks when used in daily clinical practice. This process, known as pharmacovigilance, plays a vital role in ensuring that patients receive appropriate vaccines and medicines that are safe and effective. While this may seem obvious, the process of building the necessary capacity and even recognition of the importance of this work has taken decades. Brazil is a particularly notable example because it ranks in the top five amongst the largest and the most populated countries—two characteristics that difficult the deployment and consolidation of a pharmacovigilance system.
Users also downloaded
Showing related downloaded files
Publication Building Climate Resilient and Environmentally Sustainable Health Systems in Africa(Washington, DC: World Bank, 2023-09-06)This note summarizes lessons and practices deployed in embedding climate resilience into the design of projects that received catalytic funds from The Africa Climate Resilience Investment Facility (AFRI-RES). It draws from application of the Resilience Booster Tool to specific projects, as relevant, Compendium Volume on Climate Resilient Investment in Sub-Saharan Africa (World Bank (2023) and Guidance, Standards, and Good Practice Notes developed under the program.Publication Rising to the Challenge(Washington, DC: World Bank, 2024-10-31)About 1.2 billion people - one in five people in the world – are at high risk from climate-related hazards, but much can be done to make people, business, communities, and countries more resilient. The new World Bank flagship report “Rising to the Challenge” argues that reducing climate and disaster impacts requires a combination of more rapid development, more resilient development, and targeted adaptation interventions. Development plays a key role as nobody can be resilient without access to basic infrastructure and social services, decent housing, or while living in poverty. While a 10-percent increase in income is associated with a decrease in the population at high risk by close to 100 million people, current development patterns will not be enough. An assessment of 44 countries shows that, in spite of growing attention and adaptation planning, most countries are still lagging in implementing resilience interventions, especially those related to policies and macro-fiscal dimensions, and in the monitoring and evaluation of their actions. However, the report dispels the idea that no progress is being done: a collection of case studies - with firms, governments, and public-private partnerships - shows that the private and public actors are undertaking promising adaptation and resilience efforts with measurable results and good practices that can replicated to scale up action and to build resilience for all.Publication Serbia – Toward a More Effective, Efficient, Equitable and Resilient Health System(World Bank, Washington DC, 2023)The health system in Serbia faces significant challenges arising from a long-term demographic trend and the recent shock caused by the COVID-19 pandemic. Serbia’s population is aging at a rapid pace, and the share of the population aged 65 and above almost doubled —from 9.6 percent to 18.7 percent—between 1990 and 2019. This, coupled with high prevalence of unhealthy lifestyle factors, such as smoking, heavy drinking, and high consumption of fatty and sugary diet, has contributed to a rapidly rising burden of noncommunicable diseases (NCDs). Addressing NCDs exerts significant financial pressure on the health system that has been further squeezed after more than two years of dealing with COVID-19. This is all happening in a context where the economic contraction that began in 2020 after the advent of COVID-19 pandemic and compounded with the war in Ukraine has adversely affected the country’s capacity to pay for health. The health system also has a challenge to meet population expectations, which have become more demanding after decades of strong economic growth.Publication Central African Republic Country Climate and Development Report(Washington, DC: World Bank, 2024-10-23)The Central African Republic (CAR) Climate Change and Development Report (CCDR) provides an in-depth analysis of the country’s vulnerability to climate change and its implications for sustainable development. The report identifies key challenges, including frequent extreme weather events such as floods and droughts, deforestation, and weak institutional capacity. These challenges threaten the livelihoods of rural populations, exacerbate food insecurity, and hinder economic development. However, the CCDR also highlights significant opportunities for CAR to transition toward a more resilient and sustainable future. By promoting climate-smart agriculture, sustainable forest management, and renewable energy development, the country can mitigate the effects of climate change while unlocking new economic growth avenues. The report provides strategic recommendations to strengthen institutional capacities, integrate climate action into national development plans, and mobilize climate finance to support resilience-building initiatives. The CCDR serves as a roadmap for operationalizing climate action in CAR, calling for stronger governance, enhanced stakeholder engagement, and innovative financing mechanisms to help the country adapt to climate challenges while promoting sustainable development.Publication Strategic Investment for Health System Resilience(Washington, DC: World Bank, 2024-08-26)As efforts to build emergency-ready health systems intensify across the globe, Strategic Investment for Health System Resilience: A Three-Layer Framework provides a practical investment framework and a diverse set of country cases to inform decision-making and strategic resource allocations. The framework includes layer 1, risk reduction—promoting emergency-ready primary health care, public health, prevention, and community preparedness; layer 2, detection, containment, and mitigation capabilities; and layer 3, advanced case management and surge response. This three-layer framework prioritizes interventions that prevent a public health threat from developing in the first place (layer 1), limit its spread should one emerge (layer 2), and manage a widespread crisis that compromises a health system’s ability to deliver care sustainably (layer 3). All three layers play a role in achieving health system resilience, but not all of them have been leveraged equally in the past. Strategic Investment for Health System Resilience offers a glimpse of the relatively low cost of investments in improving the operation of the weakest parts of the three layers. Layer 1 functions are estimated to cost between US$2 per capita in low-income countries and US$4 per capita in lower-middle-income countries. The framework applies equally to short-term epidemics of communicable diseases and to slow-moving trends in noncommunicable diseases. The pace of the needed response to health threats can vary, but all require a system that is resilient across multiple layers of response. Although there is no universal blueprint for every setting, it behooves all countries to seize the moment and invest in the three layers in ways that fit their needs.